Compounds with Anti-Acinetobacter Baumannii Activity

Abstract

The presently-disclosed subject matter provides a compound of Formula (I): or a pharmaceutically acceptable salt of the compound, wherein R1 is C1-4 alkyl, C1-4 alkene, or, wherein R3, R4, R5, and R6 are independently hydrogen or halogen, or R4 and R5, taken together with the atoms to which they are bound, form a 6-membered ring; and wherein X1 and X2 are independently C or N; and wherein R2 is or, wherein R7 and R8 are independently hydrogen, halogen, or C1-4 alkoxy; and the use thereof in controlling (Acinetobacter baumannii and treating A. baumannii infection.

Dependencies are inferred from the claim text.